Smoking Related Interstitial Diseases

Slide 1 · Smoking-Related Interstitial Diseases

Desquamative interstitial pneumonia • Respiratory bronchiolitis–associated ILD

Anatomic pattern • Morphology • Clinical significance

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Locate smoking-associated changes within the respiratory acinus

Recognize the defining histologic features of DIP and RB-ILD

Interpret the clinical threshold between respiratory bronchiolitis and RB-ILD

Compare disease distribution, functional effects and smoking cessation outcomes

Slide 3 · Smoking may produce obstructive and interstitial disease

Obstructive disorders

Emphysema

Chronic bronchitis

Airway-predominant physiologic impairment

Interstitial disorders

Desquamative interstitial pneumonia (DIP)

Respiratory bronchiolitis–associated ILD (RB-ILD)

Inflammation and tissue remodeling

Slide 4 · Smoking-related entities within diffuse interstitial lung disease

Smoking-related group

Classification in the chronic interstitial disease framework

DIP

Large intraalveolar collections of macrophages

RB-ILD

Bronchiolocentric smoker’s macrophages with clinical disease

Classification is based on histologic distribution and clinical phenotype.

Slide 5 · The respiratory acinus is the anatomic reference

Respiratory bronchiole

Adjacent alveoli

Simplified anatomic schematic — not histology

Why location matters

Respiratory bronchioles lead toward alveolar ducts and sacs

The dominant site of macrophages distinguishes these entities

This schematic shows compartments, not a microscopic diagnosis

Slide 6 · A common signature: The smoker’s macrophage

Dusty brown cytoplasmic pigment

Simplified anatomic schematic — not histology

Shared finding

Abundant cytoplasm with fine dusty brown pigment

Found in DIP airspaces and RB respiratory bronchioles

Pigment is descriptive, not by itself a named disease

Slide 7 · Distribution matters more than macrophages alone

DIP: Alveolar emphasis

Large airspace macrophage aggregates

Alveolar septal reaction

A predominantly intraalveolar pattern

RB-ILD: Bronchiolar emphasis

Respiratory bronchioles and adjacent alveoli

Patchy peribronchiolar changes

Clinical disease required for the ILD label

Slide 8 · Interstitial and obstructive findings can coexist

DIP frequently accompanies emphysema and airway changes

RB-ILD commonly accompanies mild centrilobular emphysema

Coexisting obstructive morphology does not exclude an interstitial lesion

Assess both airway and alveolar compartments.

Slide 9 · Smoking and idiopathic pulmonary fibrosis: A caution

Most patients with IPF are smokers

The pathogenic role of smoking in IPF remains unclarified

Association must not be presented as proof of causality

Smoking exposure ≠ established IPF mechanism

Slide 10 · Two principal patterns are distinguished anatomically

Feature

DIP

RB-ILD

Dominant site

Alveolar airspaces

Respiratory bronchioles

Macrophages

Numerous, widespread

Bronchiolocentric, patchy

Septal reaction

Mild thickening/inflammation

Peribronchiolar inflammation/fibrosis

Clinical signature

Restrictive/diffusion abnormality

Smoking plus significant clinical impairment

Slide 11 · DIP is an intraalveolar macrophage-rich process

Intraalveolar macrophage accumulation

Simplified anatomic schematic — not histology

Defining pattern

Large numbers of macrophages fill alveolar spaces

Patients are usually current or former smokers

Fibrosis is absent or mild in most descriptions

Slide 12 · Why “desquamative” is a historical misnomer

Original interpretation

Cells filling alveoli were considered shed pneumocytes

Current recognition

The predominant cells are macrophages

Teaching implication

Do not interpret the label as epithelial exfoliation

Slide 13 · DIP distribution: Alveoli are the principal compartment

Intraalveolar macrophage accumulation

Simplified anatomic schematic — not histology

Location and architecture

The diagnostic emphasis is on collections in airspaces

Alveolar septa may be mildly thickened

The finding is not centered on a single small airway

Slide 14 · Smoker’s macrophages in DIP: Abundant and pigmented

Dusty brown cytoplasmic pigment

Simplified anatomic schematic — not histology

Cytologic profile

Macrophages have voluminous cytoplasm

The cytoplasmic pigment is dusty brown

The aggregates dominate microscopic recognition

Slide 15 · Dusty brown pigment is a shared histologic clue

Macrophage pigmentation supports a smoking-related phenotype

DIP and RB-ILD share this macrophage appearance

Their anatomic distributions distinguish the patterns

Shared cytology; Different location

Conceptual schematic

Slide 16 · Surfactant lamellae may appear within DIP macrophages

Type II cell injury

Robbins suggests macrophage inclusions may derive from necrotic pneumocytes

Phagocytic vacuole

Some macrophages contain lamellar bodies

Interpretation

Lamellar bodies represent surfactant material

The proposed source of the lamellar bodies is presumptive, not definitive.

Slide 17 · DIP septa contain only a sparse inflammatory infiltrate

Alveolar walls may be thickened by mild inflammation

The infiltrate includes lymphocytes and plasma cells

Occasional eosinophils also occur

Macrophage-rich airspaces remain the dominant feature

Airspace cells predominate over septal inflammation.

Slide 18 · Cuboidal type II pneumocytes line affected alveoli

Affected septa may be covered by plump cuboidal cells

These represent type II pneumocyte changes described in DIP

Do not mistake septal lining cells for the dominant luminal macrophages

Distinguish lining epithelium from luminal macrophages.

Slide 19 · Interstitial fibrosis in DIP is generally mild

Septal fibrosis may be present but is usually limited

DIP is not defined by dense destructive interstitial scarring

Rare patients progress to interstitial fibrosis clinically

Mild baseline fibrosis ≠ zero progression risk.

Slide 20 · Emphysema may coexist with DIP

DIP component

Alveolar macrophage accumulation

Mild septal thickening

Mild restrictive functional defect

Associated smoking effects

Emphysema

Airway changes of obstructive disease

Potential mixed morphologic phenotype

Slide 21 · DIP morphology: Put the features together

Intraalveolar macrophage accumulation

Simplified anatomic schematic — not histology

Integrated H&E reading checklist

Abundant intraalveolar macrophages

Sparse septal inflammatory cells

Cuboidal pneumocytes; Fibrosis usually mild

Possible coexisting emphysema

Slide 22 · Why DIP is not simply “fibrosis”

What dominates

Macrophages occupy airspaces

Pigmented abundant cytoplasm

Alveolar rather than bronchiolar distribution

What accompanies

Mild septal thickening

Limited chronic inflammation

Usually mild interstitial fibrosis

Slide 23 · Typical DIP patient: Exposure and age

Most patients are cigarette smokers

Presentations typically occur in the fourth or fifth decade

Comparable frequency in women and men

Smoking history has high contextual value.

Slide 24 · DIP symptoms develop over weeks to months

Insidious onset

Symptoms develop gradually over weeks or months

Primary symptoms

Dyspnea and dry cough

Associated sign

Digital clubbing occurs in some patients

Slide 25 · Digital clubbing can accompany DIP

Clubbing as a common associated finding

It should be interpreted alongside smoking exposure and respiratory symptoms

Clubbing alone cannot establish DIP or identify anatomic distribution

Clinical findings require morphologic context.

Slide 26 · DIP typically produces a mild restrictive defect

Pulmonary function testing often shows mild restriction

This belongs to the broader restrictive/interstitial lung disease group

Concurrent emphysema can complicate a simple obstructive/restrictive dichotomy

The functional signal is commonly mild.

Slide 27 · Gas transfer is moderately reduced in typical DIP

Diffusing capacity is often moderately decreased

This adds functional evidence of parenchymal disease

Interpret alongside pulmonary volumes and smoking-associated co-morbidity

Reduction in diffusion supports a pulmonary process.

Slide 28 · DIP connects alveolar morphology with respiratory symptoms

Pathology

Macrophages accumulate in alveolar airspaces

Tissue response

Mild septal inflammation and thickening

Clinical phenotype

Dyspnea, cough and impaired diffusion

This is clinicopathologic correlation—not a proven single-step mechanism.

Slide 29 · Cessation and corticosteroids often improve DIP

Smoking cessation

Central intervention in a smoking-associated disorder

Associated with favorable course in typical cases

Relevant to coexisting smoking-related lung changes

Steroid response

Textbook describes an excellent typical response

Outcome is not universally benign

Treatment specifics are beyond this morphology-focused lecture

Slide 30 · DIP prognosis: Favorable is not invariable

An excellent usual treatment response

Some patients nevertheless progress to interstitial fibrosis

Assess the possibility of progression without exaggerating its frequency

“Usually responsive” does not mean “never progressive”.

Slide 31 · DIP recognition: Integrate five domains

Exposure

Current or previous smoking

Morphology

Alveolar macrophages; Mild septal reaction

Clinical context

Cough, dyspnea, mild restriction and low diffusing capacity

Slide 32 · Respiratory bronchiolitis is common in smokers

Pigmented intraluminal macrophages accumulate in respiratory bronchioles

In mild form the finding can be incidental

RB-ILD requires more than the histologic observation alone

Lesion and syndrome are not synonymous.

Slide 33 · Respiratory bronchioles anchor the RB pattern

Respiratory bronchiole

Adjacent alveoli

Simplified anatomic schematic — not histology

Anatomic location

The emphasis is on first- and second-order respiratory bronchioles

Adjacent alveolar ducts and peribronchiolar spaces may also be involved

The overall pattern is bronchiolocentric

Slide 34 · Smoking-related pigment occurs inside bronchioles

Respiratory bronchiole

Adjacent alveoli

Simplified anatomic schematic — not histology

Pigment distribution

Intraluminal smoker’s macrophages are characteristic

Pigment resembles that in DIP macrophages

Macrophage localization gives the bronchiolocentric pattern

Slide 35 · RB changes are patchy at low power

Low-power distribution

Patchy rather than evenly diffuse

Centered around small respiratory airways

Different lung regions may show different lesion density

High-power clues

Dusty brown macrophages

Submucosal lymphocytes and histiocytes

Mild fibrosis near bronchioles

Slide 36 · Macrophages extend beyond the bronchiolar lumen

Alveolar macrophages

Bronchiolar component

Simplified anatomic schematic — not histology

Bronchiole → alveolar duct

Respiratory bronchioles contain pigmented macrophages

Alveolar ducts also may contain aggregates

Peribronchiolar airspaces can contain the same cells

Slide 37 · RB inflammation lies in the small-airway wall

Patchy submucosal inflammation accompanies macrophages

The infiltrate contains lymphocytes and histiocytes

Inflammation extends into the peribronchiolar region

Airway-centered inflammation supports RB pattern.

Slide 38 · Peribronchiolar fibrosis extends into adjacent septa

Airway wall

Submucosal inflammation around bronchioles

Surrounding tissue

Mild peribronchiolar fibrosis

Adjacent septa

Fibrosis expands contiguous alveolar septa

Slide 39 · RB often coexists with centrilobular emphysema

Centrilobular emphysema is common in the same specimens

The emphysema is generally not severe description

Coexistence emphasizes the wider effects of smoking on lung structure

Do not overlook accompanying airway damage.

Slide 40 · DIP and respiratory bronchiolitis may coexist

Alveolar macrophages

Bronchiolar component

Simplified anatomic schematic — not histology

Regional heterogeneity

The same lung may contain bronchiolocentric RB and DIP elsewhere

One tissue sample does not necessarily represent every region

Localize each pattern before applying a disease label

Slide 41 · RB-ILD: Disease requires clinical significance

Common smoking lesion

Respiratory bronchiolitis on histology

Clinical corroboration

Significant symptoms, abnormal function and imaging

RB-ILD terminology

Clinical interstitial disease rather than incidental lesion

The diagnostic distinction is explicitly clinical, not only microscopic.

Slide 42 · Typical RB-ILD patients have substantial exposure

Patients are generally current smokers

Exposures often exceeding 30 pack-years

Presentation is typically in the fourth or fifth decade

The exposure profile is contextual, not a standalone diagnostic threshold

>30 pack-years is typical, not a required cutoff.

Slide 43 · RB-ILD symptoms are usually relatively mild

Symptoms often develop gradually

Cough and dyspnea predominate

Clinical severity distinguishes RB-ILD from an incidental respiratory bronchiolitis lesion

Symptoms determine clinical relevance.

Slide 44 · Abnormal imaging and physiology support RB-ILD

The disease label includes abnormal pulmonary function

Imaging abnormalities are part of the definition

The provided section does not specify a characteristic HRCT pattern

Avoid inventing a diagnostic imaging cutoff

Clinical evidence is required; Morphology alone is insufficient.

Slide 45 · Smoking cessation often improves RB-ILD

Exposure

Ongoing cigarette smoking is typical

Intervention

Smoking cessation

Course

Improvement is usual in the Robbins account

Do not infer a guaranteed or uniform response for every patient.

Slide 46 · DIP versus RB-ILD: Dominant anatomic distribution

Parameter

DIP

RB-ILD

Center of lesion

Alveolar spaces

Respiratory bronchioles

Macrophages

Large intraalveolar collections

Small-airway and adjacent airspaces

Geographic pattern

Prominent alveolar involvement

Patchy, bronchiolocentric

Associated septa

Mild inflammatory thickening

Fibrosis adjacent to bronchioles

Emphysema

May coexist

Centrilobular form is common

Slide 47 · DIP versus RB-ILD: Clinical distinctions

Parameter

DIP

RB-ILD

Exposure

Usually current/former smoker

Typically current heavy smoker

Symptoms

Dyspnea; Dry cough

Often mild dyspnea and cough

Function

Mild restriction, ↓ diffusion

Abnormality required for ILD label

Other clinical sign

Clubbing can occur

Not emphasized in source

Course

Cessation + steroids usually effective

Cessation usually improves

Slide 48 · The same pigmented cells do not establish one disease

Features shared

Smoker’s macrophages

Association with cigarette smoking

Potential coexisting emphysema

Features discriminating

Airspace-wide vs airway-centered localization

Septal pattern and distribution

Clinical lesion vs syndrome distinction

Slide 49 · Beware of making smoking a universal explanation

A smoking history is not sufficient to identify a specific ILD

Robbins leaves smoking’s pathogenetic role in IPF unresolved

Mixed obstructive and interstitial findings may occur

Morphology and clinical features must remain concordant

Exposure supports—but does not replace—diagnosis.

Slide 50 · Pulmonary Langerhans cell histiocytosis is separate

DIP / RB-ILD

Pigmented macrophages dominate

Alveolar or bronchiolocentric distributions

Smoking-associated interstitial patterns

PLCH (adjacent topic)

Langerhans cell aggregates, often with eosinophils

Scarring and irregular cystic spaces

Distinct nodular/cystic morphology

Slide 51 · An integrated interpretation is preferable to one clue

History

Smoking status, course and symptoms

Function and imaging

Evaluate significance of the interstitial process

Anatomic pattern

Describe macrophage distribution and septal reaction

A diagnosis must reconcile exposure, clinical disease and lung morphology.

Slide 52 · Sampling can alter the apparent dominant pattern

RB lesions are patchy and bronchiolocentric

DIP may coexist in a different region of the same lung

A sampled field may underrepresent regional heterogeneity

Use the broader clinical picture and available tissue context

Different regions need not show identical morphology.

Slide 53 · Case 1: A DIP-type presentation

Teaching case (hypothetical)

A current smoker in the fifth decade develops several months of dry cough and exertional dyspnea. Function tests show mild restriction with reduced diffusing capacity. A teaching section depicts many macrophages filling alveolar spaces.

Question

Which smoking-related interstitial pattern is most strongly suggested—and what makes the distribution informative?

Slide 54 · Case 1: Evidence supports DIP

Intraalveolar macrophage accumulation is the dominant defining clue

Insidious cough/dyspnea and mild restrictive impairment are compatible

The reduced diffusing capacity supports clinical parenchymal involvement

The histologic label still requires appropriate clinicopathologic correlation

Slide 55 · Case 2: An incidental smoking lesion

Teaching case (hypothetical)

A smoker has dusty brown macrophages inside respiratory bronchioles in a specimen obtained for another indication. No pulmonary symptoms, physiologic impairment or reported imaging abnormality are present in the vignette.

Question

Does this finding alone justify the diagnosis of RB-ILD?

Slide 56 · Case 2: Respiratory bronchiolitis ≠ RB-ILD

Bronchiolar pigmented macrophages are common in smokers

Respiratory bronchiolitis may be incidental

RB-ILD requires clinically significant symptoms and abnormal function/imaging

Do not promote a common histologic lesion to a clinical disease automatically

Slide 57 · Case 3: When RB becomes clinically significant

Teaching case (hypothetical)

A current smoker with substantial cumulative exposure develops slowly progressive cough and dyspnea. Physiologic testing and imaging are abnormal. Tissue shows patchy bronchiolocentric smoker’s macrophages and mild peribronchiolar fibrosis.

Question

Which findings support the RB-ILD designation rather than incidental RB?

Slide 58 · Case 3: Clinical and pathologic concordance

Bronchiolocentric macrophages establish an RB-type lesion

The symptoms, abnormal physiology and imaging meet the clinical threshold

Mild peribronchiolar fibrosis fits the source morphology

Cessation of smoking is associated with typical improvement

Slide 59 · Clinicopathologic synthesis

Question

Evidence favoring DIP

Evidence favoring RB-ILD

Where?

Alveolar airspaces

Small respiratory bronchioles

Which cells?

Numerous smoker’s macrophages

Pigmented bronchiolar macrophages

What tissue response?

Mild septal inflammation

Mild peribronchiolar fibrosis

What clinical role?

Symptomatic interstitial process

Significant RB-associated clinical disease

Slide 60 · Five defensible conclusions

DIP and RB-ILD are smoking-associated but anatomically distinct

Both contain dusty brown smoker’s macrophages

DIP primarily fills alveoli; RB lesions center on respiratory bronchioles

RB-ILD requires demonstrable clinical disease

Smoking cessation is central; DIP may respond to steroids

Location + clinical significance determine interpretation.

Slide 61 · Primary source and boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 15, “The Lung,” p. 637: Smoking-Related Interstitial Diseases.

Parent context: Chronic Diffuse Interstitial (Restrictive) Diseases, pp. 627–628; relevant classification and physiologic framework.

Adjacent differential boundary: Pulmonary Langerhans Cell Histiocytosis, p. 637. Original schematic drawings are conceptual; no diagnostic photomicrographs are reproduced.